Sponsor or institution
Clinical trials and research at TYK Medicines, Inc
As of November 12, 2026, Find a Trial lists 4 clinical trials run by TYK Medicines, Inc that are recruiting, in China. By phase: Phase 1/2 (1), Phase 3 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating TYK-00540 Tablets for Advanced Solid Tumors | Phase 1/2 | Shanghai, Shanghai Municipality and 1 other locations | Recruiting | Apr 29, 2025 |
| Evaluating TYK-00540 for patients with advanced solid tumors | Phase 1 | Hefei | Recruiting | Feb 7, 2024 |
| Evaluating TY-9591 for treating advanced lung cancer with brain metastases | Phase 2 | Beijing, Beijing Municipality | Recruiting | Jul 17, 2023 |
| Comparing TY-9591 and Osimertinib for advanced lung cancer | Phase 3 | Changsha, Hunan and 1 other locations | Recruiting | May 19, 2022 |
All recruiting trials (4)
-
Evaluating TYK-00540 Tablets for Advanced Solid Tumors
This study is testing a new medication called TYK-00540 to see if it can safely help people with advanced solid tumors, especially those with certain types of breast cancer, who haven't had success with other treatments.
-
Evaluating TYK-00540 for patients with advanced solid tumors
This study is testing a new drug called TYK-00540 to see if it is safe and how well it works for adults with advanced solid tumors.
-
Evaluating TY-9591 for treating advanced lung cancer with brain metastases
This study is testing a new drug called TY-9591 to see if it can help people with advanced lung cancer that has spread to the brain, compared to a standard treatment.
-
Comparing TY-9591 and Osimertinib for advanced lung cancer
This study is testing if a new drug called TY-9591 works better than the standard treatment Osimertinib for adults with advanced lung cancer that has specific genetic changes.
Quick answers
How many clinical trials run by TYK Medicines, Inc are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.